Two Sigma Investments’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Sell
39,802
-17,759
-31% -$296K ﹤0.01% 3598
2025
Q4
$1.04M Buy
57,561
+31,712
+123% +$546K ﹤0.01% 2882
2025
Q3
$416K Sell
25,849
-7,364
-22% -$108K ﹤0.01% 3075
2025
Q2
$362K Buy
+33,213
New +$372K ﹤0.01% 2722
2024
Q4
Sell
-20,351
Closed -$166K 3380
2024
Q3
$166K Buy
+20,351
New +$138K ﹤0.01% 2833

Other funds holding MESO

Two Sigma Investments's MESO Position: Q1 2026 in Review

Two Sigma Investments reduced its Mesoblast (MESO) stake by 31% in Q1 2026, selling an estimated $296K and leaving 39,802 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #3598.

Two Sigma Investments first reported a position in MESO in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.04M in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Two Sigma Investments held 39,802 shares of Mesoblast worth $612K as of Q1 2026.
  • Two Sigma Investments sold 17,759 Mesoblast shares in Q1 2026, an estimated $296K.
  • Mesoblast made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3598 holding.
  • Two Sigma Investments first reported a position in Mesoblast in Q3 2024 and has held it in 5 quarters since.
  • Two Sigma Investments's Mesoblast position peaked at $1.04M in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.